Previous Close | 9.41 |
Open | 9.46 |
Bid | 9.50 x 2200 |
Ask | 10.23 x 1000 |
Day's Range | 9.46 - 9.74 |
52 Week Range | 6.88 - 26.60 |
Volume | |
Avg. Volume | 339,283 |
Market Cap | 354.297M |
Beta (5Y Monthly) | 0.63 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.09 |
Earnings Date | Mar 08, 2023 - Mar 13, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 49.18 |
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
BEDFORD, Mass., January 09, 2023--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today outlined its expected milestones and the following strategic priorities for 2023:
BEDFORD, Mass., January 04, 2023--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced that management will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 2:15 p.m. ET (11:15 a.m. PT).